265 related articles for article (PubMed ID: 24764067)
1. In vivo assessment of aqueous humor dynamics upon chronic ocular hypertension and hypotensive drug treatment using gadolinium-enhanced MRI.
Ho LC; Conner IP; Do CW; Kim SG; Wu EX; Wollstein G; Schuman JS; Chan KC
Invest Ophthalmol Vis Sci; 2014 Apr; 55(6):3747-57. PubMed ID: 24764067
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium-enhanced 7.0 T magnetic resonance imaging assessment of the aqueous inflow in rat eyes in vivo.
Li L; Yuan Y; Chen L; Li M; Ji P; Gong J; Zhao Y; Zhang H
Exp Eye Res; 2017 Sep; 162():18-26. PubMed ID: 28655605
[TBL] [Abstract][Full Text] [Related]
3. Age-related changes in eye morphology and aqueous humor dynamics in DBA/2J mice using contrast-enhanced ocular MRI.
Crosbie DE; Keaney J; Tam LCS; Daniel Stamer W; Campbell M; Humphries P
Magn Reson Imaging; 2019 Jun; 59():10-16. PubMed ID: 30660703
[TBL] [Abstract][Full Text] [Related]
4. GD-DTPA enhanced MRI of ocular transport in a rat model of chronic glaucoma.
Chan KC; Fu QL; Guo H; So KF; Wu EX
Exp Eye Res; 2008 Oct; 87(4):334-41. PubMed ID: 18639546
[TBL] [Abstract][Full Text] [Related]
5. Microbead-induced ocular hypertensive mouse model for screening and testing of aqueous production suppressants for glaucoma.
Yang Q; Cho KS; Chen H; Yu D; Wang WH; Luo G; Pang IH; Guo W; Chen DF
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3733-41. PubMed ID: 22599582
[TBL] [Abstract][Full Text] [Related]
6. Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy.
Gulati V; Fan S; Zhao M; Maslonka MA; Gangahar C; Toris CB
Arch Ophthalmol; 2012 Jun; 130(6):677-84. PubMed ID: 22332206
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.
Johnson TV; Fan S; Zhan G; Camras CB; Toris CB
J Glaucoma; 2010 Aug; 19(6):356-64. PubMed ID: 20179619
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
Maus TL; Nau C; Brubaker RF
Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
[TBL] [Abstract][Full Text] [Related]
9. Aqueous Humor Dynamics in Uveitic Eyes.
Alaghband P; Baneke AJ; Galvis E; Madekurozwa M; Chu B; Stanford M; Overby D; Lim KS
Am J Ophthalmol; 2019 Dec; 208():347-355. PubMed ID: 31473215
[TBL] [Abstract][Full Text] [Related]
10. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
Wang RF; Gagliuso DJ; Mittag TW; Podos SM
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
[TBL] [Abstract][Full Text] [Related]
11. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes.
Ziai N; Dolan JW; Kacere RD; Brubaker RF
Arch Ophthalmol; 1993 Oct; 111(10):1351-8. PubMed ID: 8216015
[TBL] [Abstract][Full Text] [Related]
12. Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes.
Sharif NA; McLaughlin MA; Kelly CR; Katoli P; Drace C; Husain S; Crosson C; Toris C; Zhan GL; Camras C
Exp Eye Res; 2009 Mar; 88(3):386-97. PubMed ID: 18992242
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced MRI of ocular biotransport in normal and hypertensive eyes.
Chan KC; Fu QL; So KF; Wu EX
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():835-8. PubMed ID: 19162786
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in oclular normotensive and alpha-chymotrypsin-induced ocular hypertensive rabbits.
Puras G; Santafé J; Segarra J; Garrido M; Melena J
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1559-67. PubMed ID: 17505840
[TBL] [Abstract][Full Text] [Related]
15. Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents.
Roy Chowdhury U; Rinkoski TA; Bahler CK; Millar JC; Bertrand JA; Holman BH; Sherwood JM; Overby DR; Stoltz KL; Dosa PI; Fautsch MP
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5731-5742. PubMed ID: 29114841
[TBL] [Abstract][Full Text] [Related]
16. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients.
Toris CB; Camras CB; Yablonski ME
Am J Ophthalmol; 1999 Jul; 128(1):8-14. PubMed ID: 10482088
[TBL] [Abstract][Full Text] [Related]
17. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.
Toris CB; Camras CB; Yablonski ME
Ophthalmology; 1993 Sep; 100(9):1297-304. PubMed ID: 8371915
[TBL] [Abstract][Full Text] [Related]
18. Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.
Sponsel WE; Paris G; Trigo Y; Pena M; Weber A; Sanford K; McKinnon S
Am J Ophthalmol; 2002 Jan; 133(1):11-8. PubMed ID: 11755835
[TBL] [Abstract][Full Text] [Related]
19. Effects of brimonidine on aqueous humor dynamics in human eyes.
Toris CB; Gleason ML; Camras CB; Yablonski ME
Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
[TBL] [Abstract][Full Text] [Related]
20. The effect of topical CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure and aqueous humor dynamics in rabbits.
Inoue T; Yokoyoma T; Mori Y; Sasaki Y; Hosokawa T; Yanagisawa H; Koike H
Curr Eye Res; 2001 Aug; 23(2):133-8. PubMed ID: 11840352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
